UPDATE 3-Mylan board rebuffs Icahn pitch
626345
Mylan Laboratories Inc.&#39;s (MYL.N: Quote, Profile, Research) board on Monday rebuffed financier Carl Icahn&#39;s bid to buy the company, and said it remains committed to
202255
OK, we had an extended breather from our last look at BIND's zone file pri.example.org. It's time to finish up and get a sense of what these records mean. To go off-topic a little, recently, I had the task of setting up two OpenLDAP servers and putting together a test environment for a project with several developers and several applications including some LAMP applications. Without a working knowledge of DNS, the project would have gone amuck.
443606
Mylan Laboratories Inc. may have found the white knight it needs to check Carl Icahn&#39;s attempts to kill its $4 billion plan to acquire King Pharmaceuticals Inc.
112205
Software update patches bug in wireless drivers that left systems vulnerable.
684473
I'm trying to discover why three out of three of my selected hard-disk recorders refuse to work on my Debian Etch (Demudi) system. Once again I ask myself the relevant questions: Is it me ? Is my computer trying to tell me something ? Is it something I said ? Whatever the reason(s), my reviews of those three programs must remain in limbo until I figure out what's wrong. The applications are all known to run perfectly well on other machines, so I'm sure there's an external problem. When testing new applications one must be prepared with the newest dependencies. CVS sources are often required. Sometimes one must mutter obscure invocations. Alas, I was not sufficiently prepared. Time for a radical shift.
768370
Billionaire investor Carl Icahn yesterday offered to purchase Mylan Laboratories for $20 per share, part of his plan to derail the Canonsburg generic drug maker&#39;s proposed acquisition of King Pharmaceuticals.
303057
Wall Street financier Carl Icahn on Wednesday reaffirmed his offer to acquire the remaining shares of Mylan Laboratories Inc.  he did not already own for &#36;4.9 billion.
344031
Intel has formally dropped Wi-Fi support from its &#39;Grantsdale&#39; chipset family and from its &#39;Alderwood&#39; chipset. The chip giant will now not ship the promised add-in module which would allow PCs based on its
365018
Internet telephony application balks on IPaq and Axim Pocket PC devices.
333547
The working group for the emerging IEEE 802.20 mobile broadband standard, which was suspended last year after a fight over members&#39; real company affiliations, has changed its voting rules.
648107
Jeremy Schoemaker, who has been creating a side hobby of revealing MyBlogLog bugs over the past month, has been ironically banned from MyBlogLog. Jeremy posts on Shoemoney.com Since last night every page I visit on their site results in a 403 (Forbidden) error code. I have asked others and nobody else seems to get the error but [...]
603432
PITTSBURGH The chief executive of Mylan Laboratories says a move by Wall Street financier Carl Icahn (EYE&#39;-kahn) to halt Mylan&#39;s acquisition of King Pharmaceuticals is wrongheaded.
755767
Mylan Laboratories Inc.'s MYL.N board  on Monday rebuffed financier Carl Icahn's bid to buy the  company, and said it remains committed to its $3.37 billion  purchase of brand-name drug-maker King Pharmaceuticals Inc.  KG.N.
721552
Overture for update error don't impress Chinese customers whose systems were downed.
639161
To: ENVIRONMENTAL EDITORS  Contact: David Kalson of RF|Binder Partners, +1-518-935-1040, +1- 212-994-7513, david.kalson@rfbinder.com, for New York Regional Interconnect Inc.   ALBANY, N.Y., June 21 /PRNewswire-USNewswire/ -- New York Regional Interconnect Inc.
754264
PHILADELPHIA, Aug 19  - Shares of Mylan Laboratories Inc. (MYL.N: Quote, Profile, Research) surged more than 10 percent on Thursday after billionaire investor Carl Icahn got federal regulatory approval to buy up 11.9 percent of ...
50324
Opinion: SIPphone&#39;s one good point is that Vonage-only router/terminal adapters must say Vonage on the boxâand Vonage seems to be hurrying to do that consistently.